What is the important information in the instructions for Atropine Sulfate Eye Drops 0.01% (EIKANCE)

1. Drug name

Generic name: Atropine sulfate eye drops

Product name:EIKANCE 0.01%

2. Drug ingredients

The main ingredient of this product is atropine sulfate, with a concentration of 0.01%.

3. Drug forms

0.01% Atropine Sulfate Eye Drops (EIKANCE) is a clear, colorless solution, packaged in single-dose containers made of transparent polyethylene. Each container is individually sealed in an aluminum foil bag to ensure the stability and sterility of the solution. The single-dose design is not only convenient to carry and use, but also effectively avoids cross-contamination. Each container is for one dose only and should be discarded immediately after use to ensure safety and hygiene.

4. Treatment indications

0.01% atropine sulfate eye drops are mainly used to slow down the progression of myopia in children , and the applicable age range is 4 to 14 years old. In children whose myopia progresses rapidly, especially when the annual refractive index progression reaches or exceeds -1.0 D, low-concentration atropine intervention therapy may be considered. Low-concentration atropine slows down the progression of myopia by regulating the accommodation response of the eyeball and the growth rate of the axial length of the eye, thereby reducing the risk of high myopia and its related complications. Clinical studies have shown that early intervention is particularly important in delaying the progression of myopia, and that combined with standardized ophthalmological follow-up and eye management, better results can be achieved.

Five. Dosage and Administration

The use of 0.01% atropine sulfate eye drops should be guided and supervised by ophthalmology or optometry professionals to ensure the safety and efficacy of the medication. Standard dosing is one drop in each eye at night. After instilling the drug, slight pressure should be applied to the tear duct for about one minute in order to reduce systemic absorption of the drug. Single-dose containers are designed to facilitate accurate dosing and avoid contamination of the solution from repeated exposure to air.

The continued dosing period is critical. Studies have shown that treatment periods of less than two years may not achieve the maximum benefit of the drug, compared with the maximum duration of five years in clinical trials. forSafety and effectiveness data for children over 14 years old are relatively limited, so use in this age group requires special caution and assessment of risks and benefits under the strict guidance of professional doctors. The timing and duration of treatment should be based on regular clinical assessment, including visual acuity examination, refractive measurement, and axial length monitoring, to ensure optimal treatment.

6. Precautions for use

Each single-dose container is for one use only and should be discarded immediately after use to avoid contamination caused by reuse. Regular follow-up visits with an ophthalmologist should be performed during use to monitor changes in vision and eye health. Avoid contact with areas other than eyes and wash hands after use.

Low concentrations of atropine are well tolerated in most children, but some children may experience mild pupil dilation or transient blurred near vision. If you feel unwell, you should consult your doctor promptly. When used in combination with other eye drops or eye drops, the interval should be as directed by the doctor to avoid interference with each other's effects.

7. Clinical effects

0.01% Atropine Sulfate Eye Drops can effectively control the progression of myopia by stably regulating the eyeball adjustment mechanism and slowing down the growth of the axial length of the eye. In long-term follow-up, low-concentration atropine showed good safety and tolerability, leaving children with little impact on their daily lives and learning. Appropriate early intervention not only reduces the risk of high myopia, but also provides long-term protection for children's future visual health.

8. Storage conditions

Please store this product in a dry place at room temperature or low temperature, away from direct sunlight. Use as soon as possible after opening and ensure single-dose containers remain sealed to avoid contamination and loss of efficacy.

Reference materials:https://www.eikance.com.au/